A Study in the Treatment of Mild to Moderate Dry Eye Disease Comparing Saline to TTAX03.

Recruiting

Phase 2

TTAX03A Study in the Treatment of Mild to Moderate Dry Eye Disease Comparing Saline to TTAX03.

Sponsor:

BioTissue Holdings, Inc

Code:

NCT06780306

Conditions

Dry Eye

Dry Eye Disease (DED)

Dry Eye Disease With Severe Keratitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

TTAX03

Saline (NaCl 0,9 %) (placebo)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-09. This information was provided to ClinicalTrials.gov by BioTissue Holdings, Inc on 2025-09-19.